ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.
ArcScan, Inc. announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. that will result in a $11.15 million Preferred Series B investment into ArcScan, Inc.
July 22, 2021
by prnasia
Cambridge start-up PhoreMost raises £33m to progress PLK1 programme
Cambridge, UK-based PhoreMost has announced the closing of a £33m Series B investment round from new and existing investors.
March 26, 2021
by pharmatimes
Stelis concludes $195 million Series B and Series C fund raise
Stelis Biopharma (Stelis) announced that it has successfully concluded its Series B and Series C fund raise for a cumulative amount of $195 million.
March 19, 2021
by expresspharma
Numab closes $23.6m Series B round led by Asian investors
Swiss biotech Numab has raised CHF22m ($22.7m) in a Series B financing round, which attracted multiple new investors from Asia, including 3SBio, Mitsubishi UFJ Capital and Eisai, as well as a company board member Dr Daniel Vasella.
March 11, 2020
by pharmaceutical-technology
BlackStone Therapeutics closes $76 m Series B financing
BlackThorn also announced two appointments to its executive management team: Jane Tiller, MBChB, FRCPsych, as chief medical officer, and Laura Hansen, Ph.D., as vice president, corporate affairs. Dr. Tiller, who brings extensive clinical psychiatry and dr
June 16, 2019
by biospectrumasia
Emergency EEG maker Ceribell raises $35M in series B round
The system's headband includes a “brain stethoscope” feature that converts EEG signals to sound.
September 27, 2018
by fiercebiotech
RSP Systems Secures Series B Funding to Drive its Non-Invasive Glucose Monitor
RSP Systems A/S, the non-invasive diagnostics company, announces that it has completed the first closing of a Series B funding round amounting to €6.5 million. The round remains open for a second closing due to strong interest.
June 20, 2018
by b3cnewswire